Compared with the untreated endometriosis mice, treatment with nobiletin significantly lowered PCNA and VEGF immunostaining, and showed higher staining level of E-cadherin in both low- and high-dose of nobiletin treated groups (P<0.01). This evidence concerns the gene CDH1 and endometriosis.